CPIG
NVAX icon

Chicago Partners Investment Group’s Novavax NVAX Stock Holding History

Chicago Partners Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,978
Closed -$239K – 597
2021
Q4 		$239K Sell
2,978
-222
-7% -$38.1K 0.02% 486
2021
Q3 		$542K Sell
3,200
-2,076
-39% -$458K 0.04% 321
2021
Q2 		$1.02M Buy
5,276
+2,163
+69% +$396K 0.08% 207
2021
Q1 		$690K Buy
3,113
+1,306
+72% +$260K 0.06% 254
2020
Q4 		$229K Buy
+1,807
New +$192K 0.02% 415

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chicago Partners Investment Group's NVAX Position: Q1 2022 in Review

Chicago Partners Investment Group sold out of Novavax (NVAX) in Q1 2022, closing a stake of 2,978 shares — an estimated $239K sold.

Chicago Partners Investment Group first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $1.02M in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Chicago Partners Investment Group reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 2,978 Novavax shares in Q1 2022, an estimated $239K.
  • Chicago Partners Investment Group first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
  • Chicago Partners Investment Group's Novavax position peaked at $1.02M in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Chicago Partners Investment Group's 13F filing for Q1 2022, filed 20 May 2022.